10 completed, 7 unknown, 3 terminated, 2 recruiting. 23 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 23 | Completed 10, Unknown 7, Terminated 3, Recruiting 2, Withdrawn 1 |
Follow ganirelix: new trials by email Literature Review of ganirelix trials Research Report on ganirelix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study Elonva®, Puregon®, Orgalutran® - Ovarian Stimulation, Quality of Life | Phase 4 | Recruiting | University Hospital, Ghent | 60 | 2025-01-27 | 2025-12-26 |
| Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women ganirelix acetate - Estrogen, Premenopause | Phase 4 | Recruiting | University of Delaware | 30 | 2024-11-15 | 2026-07-02 |
| Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A. Ganirelix, Medroxyprogesterone Acetate 10 MG - Stimulation in the Ovary, Embryo | Phase 4 | Unknown | Ginefiv | 144 | 2024-10-15 | 2024-10-15 |
| Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation. Progesterone 200 MG, Ganirelix Acetate - IVF | Phase 4 | Completed | Instituto Bernabeu | 150 | 2023-12-23 | 2026-03-27 |
| GnRH Antagonist Pre-treatment for the Prevention of Asynchronous Follicular Growth Ganirelix Acetate, Cetrolix Acetate - IVF | Phase 4 | Unknown | Assaf-Harofeh Medical Center | 15 | 2021-04-01 | 2021-10-08 |
| Desogestrel Versus GnRH Antagonist in IVF/ICSI Desogestrel 0.075 MG, Orgalutran - IVF, Infertility | Phase 4 | Unknown | Casa di Cura Privata Villa Mafalda | 165 | 2020-10-01 | 2021-01-28 |
| The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles Medroxyprogesterone Acetate, Ganirelix Acetate - IVF, Infertility | Phase 4 | Unknown | Casa di Cura Privata Villa Mafalda | 396 | 2020-09-01 | 2020-12-04 |
| Cetrorelix and Ganirelix Flexible Protocol for (IVF) Ganirelix Acetate, Cetrorelix Acetate - Infertility/Sterility | Phase 4 | Unknown | Università degli Studi 'G. d'Annunzio' Chieti e Pescara | 100 | 2017-11-15 | 2018-03-27 |
| To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran® Ganirelix acetate - Controlled Ovarian Stimulation | Phase 4 | Completed | LG Life Sciences | 255 | 2016-10-01 | 2019-07-02 |
| Progevera 10 mg® Versus Orgalutran® in Ovarian Stimulation Cycles of Oocyte Donors Progevera, Orgalutran - Infertility | Phase 4 | Completed | Fundació Privada Eugin | 232 | 2016-06-01 | 2017-09-13 |
| Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation Follistim, Ganirelix, Menotropins - Egg Donation | Phase 4 | Completed | Michigan Reproductive Medicine | 38 | 2014-04-01 | 2018-03-23 |
| Delayed Start to Ovarian Stimulation Ganirelix acetate - Diminished Ovarian Reserve, Infertility | Phase 4 | Terminated | University of California, San Francisco | 30 | 2012-05-01 | 2021-06-15 |
| Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist GnRH agonist, GnRH antagonist, hP-hMG - Reproductive Endocrinology, Fertility | Phase 4 | Completed | Universitair Ziekenhuis Brussel | 120 | 2010-09-01 | 2013-06-28 |
| Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF) Mild stimulation - in Vitro Fertilization, Ovulation Induction | Phase 4 | Terminated | UMC Utrecht | 147 | 2009-01-01 | 2019-01-29 |
| Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients Oral contraceptive pill and microdose lupron, E2 patch/antagonist - Infertility | Phase 4 | Withdrawn | Weill Medical College of Cornell University | 2009-01-01 | 2013-06-25 | |
| MENOPUR® Versus FOLLISTIM® Menotropin, Progestrone vaginal insert, follitropin beta - Infertility | Phase 4 | Completed | Ferring Pharmaceuticals | 173 | 2008-12-01 | 2011-11-02 |
| A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF) Ovarian stimulation - In Vitro Fertilization | Phase 4 | Terminated | Bart CJM Fauser | 34 | 2008-10-01 | 2013-07-22 |
| Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation Arvekap 0.1 mg (Triptorelin, Ipsen, France), Ganirelix 0.25 (Orgalutran, Organon, The Netherlands) - Infertility | Phase 4 | Unknown | Eugonia | 300 | 2005-09-01 | 2006-12-29 |
| Luteal Phase FSH in the IVF Poor Responder follitropin beta, ganirelix acetate - Infertility | Phase 4 | Completed | University of Pennsylvania | 20 | 2005-09-01 | 2015-12-03 |
| Early Follicular Supplementation of Ganirelix in IVF 2004 Ganirelix - Infertility, IVF Treatment | Phase 4 | Completed | The Baruch Padeh Medical Center, Poriya | 50 | 2004-01-01 | 2008-06-27 |
Showing 20 of 23. Sign in to see all of them.
Infertility (12) · Aneuploidy (1) · Ovarian Hyperstimulation Syndrome (1) · Polycystic Ovary Syndrome (1) · Primary Ovarian Insufficiency (1)
Eugonia (3) · Casa di Cura Privata Villa Mafalda (2) · Assaf-Harofeh Medical Center (1) · Bart CJM Fauser (1) · EMD Serono (1) · Ferring Pharmaceuticals (1) · Fundació Privada Eugin (1) · Ginefiv (1) · Instituto Bernabeu (1) · LG Life Sciences (1) · Michigan Reproductive Medicine (1) · The Baruch Padeh Medical Center, Poriya (1) · UMC Utrecht (1) · Universitair Ziekenhuis Brussel (1) · University Hospital, Ghent (1)
United States (6) · Belgium (3) · Greece (3) · Italy (3) · Israel (2) · Netherlands (2) · Spain (2) · South Korea (1)
Tryfon Lainas, PhD (3) · Bart C Fauser, Prof, PhD (1) · Eduardo Kelly, MD, MBA (1) · Gian Mario Tiboni, professor (1) · Jody Greaney, PhD (1) · Kurt T Barnhart, MD, MSCE (1) · Michael S Mersol-Barg, MD (1) · Mitchell Rosen, MD (1) · Nick S Macklon, Prof, PhD (1) · Rebeca Begueria, Dr (1) · Yohnny S Younis, MD (1) · Zev Rosenwaks, M.D. (1)
PMID 18403419, PMID 20008886, PMID 30927417, PMID 38577571
2023 (2), R21AG090810 (1)